vaccination H1N1
Showing 1 - 25 of >10,000
H1N1v Influenza Trial in Gentofte/Copenhagen, Næstved (Focetria)
Completed
- H1N1v Influenza
- Focetria
-
Gentofte, Denmark
- +1 more
Nov 14, 2022
Influenza Trial in Baltimore (H5N1 pISV)
Completed
- Influenza
- H5N1 pISV
-
Baltimore, MarylandCenter for Immunization Research, Johns Hopkins Bloomberg School
Feb 15, 2022
Avian Influenza, H1N1 Influenza, Influenza Trial in Nashville (AS03, Influenza Virus Vaccine, Monovalent A/H3N2v
Completed
- Avian Influenza
- +2 more
- AS03
- +2 more
-
Nashville, TennesseeVanderbilt University Medical Center - Vanderbilt Institute for
Jan 25, 2022
Pregnant and Lactating Individuals & Newborns COVID-19
Recruiting
- SARS-CoV2 Infection
- +4 more
-
Hamilton, Ontario, Canada
- +6 more
Nov 8, 2021
Vaccination Promotion Trial in Canada (Motivational Interviewing, Information flyer)
Completed
- Vaccination Promotion
- Motivational Interviewing
- Information flyer
-
Surrey, British Columbia, Canada
- +5 more
Apr 26, 2021
Motivational Interviewing Trial in Montréal, Québec, Sherbrooke (Motivational interviewing)
Completed
- Motivational Interviewing
- Motivational interviewing
-
Montréal, Quebec, Canada
- +3 more
Apr 26, 2021
Immunogenicity of Novel H1N1 Vaccination Among HIV-Infected
Unknown status
- Influenza
- HIV Infections
-
San Diego, California
- +2 more
Nov 5, 2020
Heart Failure Trial in Montreal (Influenza vaccination administration)
Recruiting
- Heart Failure
- Influenza vaccination administration
-
Montreal, Quebec, CanadaMcGill University Health Centre
Aug 16, 2022
Influenza A H1N1 Trial in London (Infectious Titre 1, Infectious Titre 2, Infectious Titre 3)
Recruiting
- Influenza A H1N1
- Infectious Titre 1
- +3 more
-
London, United KingdomhVIVO Services Ltd
Oct 6, 2022
Influenza, Human Trial in Morayfield (CODA-VAX H1N1, Flucelvax Quad, Saline)
Active, not recruiting
- Influenza, Human
- CODA-VAX H1N1
- +2 more
-
Morayfield, Queensland, AustraliaAmy Goh, Study Coordinator
Jun 24, 2022
Influenza, Human, Infections, Respiratory Tract Infections Trial in United States (aH5N8c on Day 1, aH5N6c on Day 1, aH5N8c on
Not yet recruiting
- Influenza, Human
- +4 more
- aH5N8c on Day 1
- +4 more
-
Cullman, Alabama
- +8 more
May 15, 2023
Malignant Pleural Mesothelioma Trial in Edegem, Ghent, Sint-Niklaas (Dendritic cell vaccination, Atezolizumab,
Not yet recruiting
- Malignant Pleural Mesothelioma
- Dendritic cell vaccination
- +2 more
-
Edegem, Antwerp, Belgium
- +2 more
Feb 28, 2023
Esophageal Cancer, Pancreas Cancer, Ovarian Cancer Trial in Edegem (IL15-transpresenting WT1-targeted Dendritic Cell Vaccine)
Not yet recruiting
- Esophageal Cancer
- +3 more
- IL15-transpresenting WT1-targeted Dendritic Cell Vaccine
-
Edegem, BelgiumAntwerp University Hospital
Jul 19, 2023
HIV-1-infection Trial in Pathum Wan (VRC07-523LS, PGDM1400LS, N-803)
Not yet recruiting
- HIV-1-infection
- VRC07-523LS
- +7 more
-
Pathum Wan, Bangkok, Thailand
- +1 more
Mar 8, 2023
Influenza, Human, Infections, Respiratory Tract Infections Trial in Philippines, United States (Low dose A/H2N3c + standard dose
Not yet recruiting
- Influenza, Human
- +4 more
- Low dose A/H2N3c + standard dose MF59
- +5 more
-
Rockville, Maryland
- +7 more
May 26, 2023
Influenza, Human Trial (FLU Q-PAN H5N8 Formulation 1, AS03B, AS03A)
Not yet recruiting
- Influenza, Human
- FLU Q-PAN H5N8 Formulation 1
- +3 more
- (no location specified)
Jul 27, 2023
Infections, Rotavirus Trial in Worldwide (PCV-free liquid formulation of GSK's oral live attenuated HRV vaccine, Lyophilized
Completed
- Infections, Rotavirus
- PCV-free liquid formulation of GSK's oral live attenuated HRV vaccine
- Lyophilized formulation of GSK's oral live attenuated HRV vaccine
-
Birmingham, Alabama
- +36 more
Feb 25, 2022
Diabetes, Type 1 Trial in Aarhus (Vaxigrip Tetra Sanofi Pasteur Europe)
Recruiting
- Diabetes Mellitus, Type 1
- Vaxigrip Tetra Sanofi Pasteur Europe
-
Aarhus, DenmarkAarhus University Hospital
Dec 14, 2022
Children After Hospitalization in Intensive Care Unit
Not yet recruiting
- Renal Disease
- +7 more
- neurocognitive tests
-
Calgary, Alberta, Canada
- +7 more
Nov 3, 2023
Guidelines VAccination in Type 1 DIabetes Mellitus Patients
Not yet recruiting
- Type 1 Diabetes
- Covid-19 vaccination
- +3 more
- (no location specified)
Jul 28, 2022
Influenza Trial in Iowa City (DCVC H1 HA mRNA vaccine, Quadrivalent Recombinant Seasonal Influenza Vaccine, Sodium Chloride,
Not yet recruiting
- Influenza
- DCVC H1 HA mRNA vaccine
- +2 more
-
Iowa City, IowaUniversity of Iowa Hospitals & Clinics - Department of Internal
Jul 6, 2023
Vaccination Hesitancy, COVID-19 Trial in London (Behavioural science-informed text messages, Control)
Completed
- Vaccination Hesitancy
- COVID-19
- Behavioural science-informed text messages
- Control
-
London, United KingdomNHS England
Aug 11, 2023
Immune Response Trial in London (Intervention snack, Control snack)
Recruiting
- Immune Response
- Intervention snack
- Control snack
-
London, United KingdomKing's College London
Aug 24, 2022
Influenza A Virus, H5N1 Subtype Trial in United States (VN, IN, dk/BANG)
Completed
- Influenza A Virus, H5N1 Subtype
- VN
- +6 more
-
San Diego, California
- +5 more
Jun 30, 2020